Loading organizations...
§ Private Profile
RxLive, Asparia (acquired), Safkan, Intelligent Observation, Velano Vascular (acquired), Tango is a company.
Key people at RxLive, Asparia (acquired), Safkan, Intelligent Observation, Velano Vascular (acquired), Tango.
RxLive provides a value-based pharmacy platform, integrating clinical pharmacists into healthcare. It offers telehealth services, proprietary software, and analytics for targeted medication interventions. This approach optimizes management, enhances clinical outcomes, and generates financial value by leveraging pharmacist expertise within health systems.
Mark and Kristen Engelen founded RxLive in 2017, recognizing pharmacists' untapped potential to impact patient health and efficiency. This insight led to building a technology-driven system embedding pharmacists into patient care. RxLive was later acquired by Scriptology, expanding its market reach.
The company serves patients, providers, employers, payers, and health systems, enabling enhanced care and effective medication cost management. RxLive’s vision is to redefine value-based pharmacy, establishing integrated pharmacist care as a cornerstone of patient-centric healthcare, maximizing financial and clinical benefits.
Asparia developed patient engagement solutions for healthcare systems. Its core offering included actionable appointment reminders and preventive care via a SaaS platform. Integrating with Electronic Health Records, this technology created a closed-loop system for automated patient communication and improved health outcomes.
Kamal Anand founded Asparia in 2019, driven by the insight that efficient patient communication was crucial for optimizing healthcare operations and patient well-being. He aimed to automate and personalize patient outreach. Asparia was acquired by Intrado Corporation in December 2020, integrating into their technology services.
Asparia served healthcare entities, enhancing patient adherence and reducing missed appointments. Its vision focused on improving patient experience through intelligent, automated interactions. By streamlining communication, Asparia empowered providers to deliver proactive, patient-centric care efficiently.
Safkan Health develops medical devices for ear care, centered on OtoSet, an FDA-cleared, automated ear-cleaning system. OtoSet safely and efficiently removes impacted cerumen (earwax) via a headset delivering warmed water and suction, offering a novel solution to this issue.
Co-founded in 2016 by brothers Sahil and Aadil Diwan, Safkan Health originated from Aadil’s personal struggle with chronic earwax, leading him to invent a more effective solution. Sahil then commercialized this technology, recognizing a broad need for improved ear hygiene.
The company primarily serves healthcare providers, including audiologists and general practitioners, using OtoSet for in-office earwax removal. Safkan Health envisions modernizing ear care, making it accessible and comfortable. They aim to establish OtoSet as the new standard for cerumen management, improving patient hearing.
Intelligent Observation develops a hand hygiene compliance monitoring system, reducing healthcare-acquired infections (HAIs) in hospitals. Its solution uses smart sensors and real-time technology to track and improve staff hand washing. Replacing visual observation with automated data provides actionable insights for infection prevention.
Seth Freedman founded Intelligent Observation in 2019, driven by the need to address HAIs. He recognized inconsistent hand hygiene as a major contributor and existing monitoring methods ineffective. His insight was to create an automated, precise system for reliable compliance measurement. The company was later acquired by HID.
Intelligent Observation serves hospitals and healthcare facilities, elevating infection control and patient safety. Its vision is to create safer hospital environments by reducing HAIs. They aim to establish their automated monitoring system as standard, fostering consistent hand hygiene and saving lives.
Velano Vascular developed PIVO, a needle-free blood draw technology. This system enables providers to obtain blood samples directly from a patient's existing intravenous (IV) line, eliminating venipunctures. The technology aims for a humane, comfortable blood collection experience for hospitalized patients, minimizing discomfort.
Founded in 2012 by Eric M. Stone and Pitamber Devgon, Velano Vascular's insight arose from recognizing patient discomfort and complications from repetitive needle sticks. They envisioned a "one-stick hospital stay" and developed PIVO. Becton Dickinson (BD) acquired the company on July 20, 2021.
The company served hospitals and healthcare providers, improving patient experience and clinical efficiency. Velano Vascular's vision was to transform blood collection, making it more humane and reducing patient burden. They aimed for painful venipunctures to become obsolete.
***
Due to reaching the maximum search query limit, I am unable to provide a company profile for Tango.
tango (formerly Professional Health Care Network, or PHCN) is a Phoenix, AZ-based leader in home-based post-acute care management services, providing a value-based care enablement platform for payers, risk-bearing entities, and providers serving Medicare Advantage, Managed Medicaid, and dual-eligible populations.[1][2][4] It empowers patients to receive high-quality care at home, addressing challenges like readmission avoidance, Star and HEDIS improvements, and total cost reduction through proprietary technology, a capitated model, and a nationwide home health network—achieving stats like 100% referral placement, 2-day faster start of care, 10.1% 30-day readmission rate (vs. 15.4% national average), and 98% member satisfaction.[2][4]
tango serves health plans, providers, and patients by optimizing post-acute transitions, increasing access, improving outcomes, and simplifying administration, with recent growth via partnerships (e.g., AmeriHealth Caritas in Pennsylvania) and expansions into new states.[1][2][4] Its momentum includes accelerated scaling post-2022 rebrand, backed by investments from The Vistria Group, enabling nationwide in-home care strategies amid rising demand.[1][4]
tango traces its roots to 2001, when PHCN was established in Arizona as a statewide home health network, introducing an innovative capitated model and proprietary intake software.[4] From 2019-2021, Serent Capital invested, fueling launches in Colorado, New Mexico, and Nevada, plus NCQA accreditation in Utilization Management—building scale beyond its foundational Arizona focus.[4]
The pivotal 2022 rebrand to tango marked its "accelerated growth" phase, with investment from The Vistria Group, a new CEO (Brian Lobley), and leadership enhancements to amplify platform capabilities and strategic partnerships.[1][4] This evolution positioned tango as a national enabler of payer-provider collaboration for home care, humanizing its mission through values like integrity, excellence, and innovation.[4]
(Note: The query lists RxLive, Asparia, Safkan, Intelligent Observation, and Velano Vascular as acquired entities potentially linked to tango; however, search results show no direct connection, suggesting they may relate to separate healthcare investors or unrelated firms.[No relevant results])
tango rides the surging trend of home-based care, fueled by post-COVID demand for cost-effective alternatives to facility stays, value-based reimbursement shifts, and aging populations straining Medicare/Medicaid systems.[1][2] Timing is ideal amid payer-provider pressures for readmission penalties avoidance and Star ratings boosts, where tango's platform amplifies in-home strategies nationwide.[1][4]
Market forces like rising healthcare costs (e.g., 15.4% national readmission average) favor its model, which cuts totals via faster placements and outcomes—positioning tango as a key ecosystem player partnering with plans to manage post-acute care at scale.[2] It influences the landscape by enabling collaborative networks, tech-driven efficiencies, and geographic expansions, bridging gaps in access for vulnerable patients.[1][2][4]
tango is primed for further national dominance in post-acute home care, leveraging Vistria's backing and new leadership to deepen payer partnerships, innovate tech (e.g., AI-enhanced placements), and enter more states amid booming demand projected through 2030.[1][4] Trends like value-based care mandates, telehealth integration, and Medicaid redeterminations will shape its path, potentially evolving it into a full-spectrum home health platform influencing policy and outcomes.
This builds on tango's core strength—delivering compassionate, high-value in-home care—solidifying its role as payers and providers prioritize home over hospital.
Key people at RxLive, Asparia (acquired), Safkan, Intelligent Observation, Velano Vascular (acquired), Tango.
